Clinical characteristics of triple-negative breast cancer: Experience in an Asian developing country

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 3, 2009, Pages 395-398

  Tan, G H ^a   Taib, Nur Aishah ^a   Choo, W Y ^a   Teo, S H ^b   Yip, Cheng Har ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

Author keywords

Ethnicity; HER2 over expression; Hormone receptors; Prognostic factors; Triple negative breast cancer

Indexed keywords

EID: 77951152624     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007). Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer, 109, 1721-8.
2. Bertucci F, Finetti P, Cervera N, et al. (2008). How basal are triple-negative breast cancers? Int J Cancer, 123, 236-40.
3. Cheang MC, Voduc D, Bajdik C, et al (2008). Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res, 14, 1368-76.
4. Cleator S, Heller W, Coombes RC (2007). Triple-negative breast cancer: therapeutic options. Lancet Oncol, 8, 235-44.
5. Dent R, Hanna WM, Trudeau M, et al (2008). Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat, (in press).
6. Dent R, Trudeau M, Pritchard KI, et al (2007). Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 3, 4429-34.
7. Deshpande AD, Jeffe DB, Gnerlich J, et al (2008). Racial disparities in breast cancer survival: an analysis by age and stage. J Surg Res, (in press).
8. Greene FL PD, Fleming ID e tal (2002.). AJCC Cancer Staging Manual 6th Ed. New York. Springer.
9. Kreike B, van Kouwenhove M, Horlings H, et al (2007). Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res, 9, R65.
10. Liu ZB, Liu GY, Yang WT, et al (2008). Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients. Oncol Rep, 20, 987-94.
11. Lund MJ, Butler EN, Bumpers HL, et al (2008). High prevalence of triple-negative tumors in an urban cancer center. Cancer, 113, 608-15.
12. Lund MJ, Trivers KF, Porter PL, et al (2008). Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat, (in press).
13. Nishimura R, Arima N (2008). Is triple negative a prognostic factor in breast cancer? Breast Cancer, (in press).
14. Rakha EA, El-Sayed ME, Green AR, et al (2007). Prognostic markers in triple-negative breast cancer. Cancer, 109, 25-32.
15. Rakha EA, Tan DS, Foulkes WD, et al (2007). Are triplenegative tumours and basal-like breast cancer synonymous? Breast Cancer Res, 9, 404; author reply 405.
16. Reis-Filho JS, Tutt AN (2008). Triple negative tumours: a critical review. Histopathology, 52, 108-18.
17. Tan DS, Marchio C, Jones RL, et al (2008). Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat, 111, 27-44.
18. Yin WJ, Lu JS, Di GH, et al (2008). Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat, (in press).